2015
DOI: 10.1016/j.polymer.2014.12.020
|View full text |Cite
|
Sign up to set email alerts
|

Nitric oxide-releasing S-nitrosothiol-modified silica/chitosan core–shell nanoparticles

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
9
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 15 publications
(9 citation statements)
references
References 34 publications
0
9
0
Order By: Relevance
“…In recent years, nanoparticle systems for intracellular NO delivery have attracted significant attention [12] to address problems associated with traditional NO donors such as low stability, burst release, and low intracellular delivery efficiency. [7,13] For examples, polymer, [14][15][16] silica, [17,18] and metal based [19] nanoparticles have been reported for NO delivery, either by encapsulation of commercial NO donors or post modification of NO donating moieties. Porous silica nanoparticles are reported to increase the stability of SNO compared to nonporous counterparts due to the so-called "cage effect".…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…In recent years, nanoparticle systems for intracellular NO delivery have attracted significant attention [12] to address problems associated with traditional NO donors such as low stability, burst release, and low intracellular delivery efficiency. [7,13] For examples, polymer, [14][15][16] silica, [17,18] and metal based [19] nanoparticles have been reported for NO delivery, either by encapsulation of commercial NO donors or post modification of NO donating moieties. Porous silica nanoparticles are reported to increase the stability of SNO compared to nonporous counterparts due to the so-called "cage effect".…”
Section: Introductionmentioning
confidence: 99%
“…[17] SNO modified silica nanoparticles have been applied for various cellular delivery applications. [18,[20][21][22] Nevertheless, cancer cells have higher GSH concentration (up to 10 mm) in their cytosol compared to normal cells (1-2 mm). [23,24] This variation is expected to produce more intracellular NH 3 instead of NO in GSH rich cells, thus limiting the efficacy of NO donors.…”
Section: Introductionmentioning
confidence: 99%
“…Polyurethane (PU) has gained acceptance in the biomedical eld for its excellent mechanical properties and biocompatibility. [1][2][3][4][5] Their segmented block copolymer character endows PUs with a wide range of versatility in terms of tailoring their related properties to satisfy specic medical requirements. PU materials have been widely used in articial hearts, pacemaker lead insulation, implantable cardiac valves and so forth.…”
Section: Introductionmentioning
confidence: 99%
“…4,5 To address these issues, materials which can be decomposed to release NO have been developed as exogenous NO donors for clinical use, including organic nitrates, nitrites, nitrosamines, metal-NO complexes, S-nitrosothiols (RSNOs), and N-diazeniumdiolates (NONOates). [6][7][8][9][10][11][12][13] Among these, NONOates have gained particular attention for their spontaneous dissociation to give off two moles of NO per mole of donor under physiological conditions (i.e. 37 °C, pH 7.4).…”
Section: Introductionmentioning
confidence: 99%